These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2675247)

  • 21. [Systolic, diastolic and pulse pressure: therapeutic options].
    Montereggi A
    Ital Heart J Suppl; 2001 Apr; 2(4):375-80. PubMed ID: 19397010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension update for the 1980s.
    Lowenthal DT; Swartz CD
    Prim Care; 1985 Mar; 12(1):101-15. PubMed ID: 2859624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Principles of drug therapy in hypertension.
    Shetty MA; Hegde BM
    J Indian Med Assoc; 1999 Mar; 97(3):106-9. PubMed ID: 10652911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent blood pressure control: potential consequences for outcome.
    Leenen FH
    Can J Cardiol; 1999 May; 15 Suppl C():13C-18C. PubMed ID: 10380687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
    McAlister FA; Levine M; Zarnke KB; Campbell N; Lewanczuk R; Leenen F; Rabkin S; Wright JM; Stone J; Feldman RD; Lebel M; Honos G; Fodor G; Burgess E; Tobe S; Hamet P; Herman R; Irvine J; Culleton B; Petrella R; Touyz R;
    Can J Cardiol; 2001 May; 17(5):543-59. PubMed ID: 11381277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [French as 2005-recommendations on the management of arterial hypertension].
    Chamontin B; Halimi JM
    Arch Mal Coeur Vaiss; 2007 Jan; 100(1):42-6. PubMed ID: 17405553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of arterial hypertension: 1993 recommendations].
    Leeman M
    Rev Med Brux; 1994; 15(4):236-40. PubMed ID: 7938996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term treatment of hypertension in 1983].
    Weidmann P
    Schweiz Med Wochenschr; 1983 Jul; 113(27-28):984-95. PubMed ID: 6412360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
    White WB
    Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2004 May; 145(18):949-56. PubMed ID: 15188641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension in Children and Adolescents.
    Daniels SR; Loggie JM
    Phys Sportsmed; 1992 Mar; 20(3):120-34. PubMed ID: 27438642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of high blood pressure in the young.
    Kotchen JM; Holley J; Kotchen TA
    Semin Nephrol; 1989 Sep; 9(3):296-303. PubMed ID: 2675247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differential therapy of exercise hypertension].
    Klaus D
    Herz; 1987 Apr; 12(2):146-55. PubMed ID: 3583208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.